AliveCor, a US FDA-cleared personal electrocardiogram (ECG) technology company, today announced its entry in the Indian market with the launch of its clinically-validated personal ECG device, KardiaMobile 6L.

The personal ECG device is the world’s only six-lead, FDA-cleared personal ECG device, the company said.

It can detect three most common arrhythmias or irregular heartbeat — atrial fibrillation (AFib), bradycardia, and tachycardia. These conditions require regular monitoring. People can test themselves for these arrhythmias at home. The device gives patients the ability to record a medical-grade ECG in just 30 seconds, AliveCor said.

The device is small enough to fit in a pocket. Users can check their heartbeat from their smartphone.

Priya Abani, Chief Executive Officer, AliveCor, said, “With hundreds of millions at risk for heart disease across the globe, accessible heart care has never been more important. We are committed to innovating digital health services in India by offering patients

Read More

  • Apple is expanding its Apple Care Plus warranty coverage to include two repairs per year for accidental damage instead of one.
  • The changes apply to iPhones, Macs, iPads, and the company’s newly unveiled Apple Watches.
  • The move comes months after Apple CFO Luca Maestri said Apple Care would take a hit during Q3 due to closed retail stores and overall “economic weakness.”
  • Visit Business Insider’s homepage for more stories.

Apple is expanding its coverage offered through its Apple Care Plus warranty program, making it easier for you to get your device fixed if it’s damaged.

iPhones are now covered for two fixes a year instead of one, regardless of which of the two warranty packages you choose. The changes also apply to the company’s new Apple Watches that were unveiled during Tuesday’s product launch, according to MacRumors, who was the first to find the upgrades, as well as to Macs

Read More

MILFORD, Ohio, Sept. 1, 2020 /PR Newswire/ — Control Bionics announces the newest addition to its Augmentative and Alternative Communication (AAC) device line, the GridPad Trilogy™ communication solution. The new neuro-based voice output communication aid is intended to help people living with a range of conditions, including ALS, Spinal Muscular Atrophy (SMA), Cerebral Palsy and Spinal Cord Injury, find their voice. 

Offering touch control, eye control, and NeuroNode™ 3.0 control within the same system, the GridPad Trilogy is a unique 3-in-1 AAC device that progresses and grows with clients and their abilities. It allows for faster communication, at rates up to 133 percent that of other systems. And, because it offers multiple access methods within the same system, the traditional insurance barriers (limits on access methods and features) are alleviated, making it accessible to those who need it most.

“Our mission is to develop accessible, leading-edge AAC devices that

Read More